Log book

A successful “Green strategy” to differentiate from competitors

19 September 2019 | Alcim's articles

More than 20 years ago, the “green wave” swept through the industry. We were then talking about “green washing”, referring to a set of more or less coordinated, opportunistic actions that were used to make the offers in place “greener”. But some companies have used this underlying thought to reinvent themselves. They have been able […]

Read more

Photobiomodulation therapy: the power of light

12 September 2019 | Alcim's articles

Photobiomodulation could reduce some of the side effects of cancer treatments such as mucositis and dermatitis. Doctors have high hopes for this new therapy, although they are waiting for a proof of efficacy and tolerance. Moreover, photobiomodulation has a large potential, as this procedure is not limited to oncology. Photobiomodulation, a new therapy to treat […]

Read more

Maturation of Liquid Biopsy as a tool to optimize cancer treatment

1 August 2019 | Alcim's articles

Alcimed, an innovation & new business consulting firm, has explored the trends in the liquid biopsy field and discusses some of the challenges as players move from the Non-invasive Prenatal Testing (NIPT) market toward further validation in oncology. Liquid biopsy’s first application was in non-invasive prenatal testing with an explosive market penetration. Liquid biopsy has […]

Read more

Interventional oncology, a new weapon against cancer

30 July 2019 | Alcim's articles

As part of the demand for more personalized and less aggressive treatments, interventional oncology represents a major field of innovation for cancer treatment. While it makes it possible both to optimize the diagnosis and to expand the therapeutic arsenal, it faces obstacles in terms of funding and accessibility.  To mark the opening of a high-tech […]

Read more

Bioprinting, an upcoming revolution?

25 July 2019 | Alcim's articles

In April, researchers at Tel Aviv University succeeded in recreating a vascularized heart through 3D printing. Even if the organ was the size of a cherry, the progress is immense, and research is getting closer to the ultimate goal of reconstructing organs. The field of bioprinting is booming as many applications are being developed. Alcimed, […]

Read more

The promises of blockchain: The law behind crypto-health!

12 July 2019 | Alcim's articles

While the popularity of Bitcoin has gradually run out of steam, following the fall in its value, the general enthusiasm has now shifted to the technology that supported it: blockchain. The expectations fostered by this new way of transmitting information are such that blockchain is becoming an essential innovation theme in all sectors. Alcimed, a […]

Read more

A solution to the lack of effectiveness of treatments for neurodegenerative diseases: targeting inflammation!

9 July 2019 | Alcim's articles

Due to the lack of certainty about their mechanism of action, research surrounding neurodegenerative diseases seems to be at an impasse. However, today, other therapeutic approaches are being considered, starting with neuroinflammation. Alcimed, an innovation and new business consulting firm, follows the advances of this research, which is opening up new treatment opportunities. While current […]

Read more